Background Epstein-Barr virus (EBV) is strongly implicated in the development of multiple sclerosis (MS) but whether ...

Background The effectiveness of disease-modifying therapies (DMTs) in multiple sclerosis (MS) declines with age, while ...

1 Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan 2 Department of Haematology, Graduate School of Medicine, Chiba University, Chiba, Japan Correspondence to Dr ...

Correspondence to Dr Claudio Liguori, Department of Systems Medicine, Neurophysiopathology Unit, University of Rome “Tor Vergata”, Viale Oxford 81 Rome 00133, Italy; dott.claudioliguori{at}yahoo.it ...

Botulinum toxin, the most potent biological toxin, has become a powerful therapeutic tool for a growing number of clinical applications. This review draws attention to new findings about the mechanism ...

Background: Assessment of patients with mild traumatic brain injury (mTBI) is predominantly done using the Glasgow Coma Scale (GCS). While the GCS is universally accepted for assessment of severity of ...

1 Rudolf Magnus Institute of Neuroscience, Department of Neurology, Utrecht, The Netherlands 2 Department of Intensive Care, University Medical Center Utrecht, Utrecht, The Netherlands Correspondence ...

Objective The PREDICT-PD study aims to identify increased risk of Parkinson’'s disease (PD) using online assessments of previously identified risk and early features of PD and an evidence-based ...

Department of Medicine, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand Correspondence to: R J Siegert Rehabilitation Teaching and Research Unit, ...

aDepartment of Ophthalmology, University of Alabama School of Medicine, 601 700 South 18th Street, Birmingham, Alabama, USA, bNeuro-ophthalmology Unit, University of California School of Medicine, San ...

Correspondence to Dr A J Larner, Cognitive Function Clinic, Walton Centre for Neurology and Neurosurgery, Lower Lane, Liverpool L9 7LJ, UK; a.larner{at}thewaltoncentre.nhs.uk While taking the history ...

Objective To report the clinical and immunological characteristics of 22 new patients with glial fibrillar acidic protein (GFAP) autoantibodies. Methods From January 2012 to March 2017, we recruited ...